Thirteen African countries have recently launched the largest clinical trial of COVID-19 treatment in Africa with international research institutions. They will share data and jointly study treatments for patients with mild and moderate COVID-19 to avoid hospital overload and protect Africa’s already fragile health systems with limited intensive care facilities.
The clinical trial will be conducted in 19 locations in 13 countries: Burkina Faso, Cameroon, Côte d’Ivoire, the Democratic Republic of the Congo, Equatorial Guinea, Ethiopia, Ghana, Guinea, Kenya, Mali, Mozambique, Sudan and Uganda, and led by local doctors to study suitable for African countries.
Home and suitable treatments for COVID-19 in health care systems that often lack funding to prevent mild and moderate symptoms from developing into severe diseases and curb the spread of the virus.
Dr. John Kengersson, director of the African Centers for Disease Control and Prevention, said that Africa needs such large-scale clinical trials to address the novel coronavirus problem unique to Africa.
